Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Cash from Discontinued Operations (2017 - 2019)

Healthstream (HSTM) reported Cash from Discontinued Operations of 93000.0 for Q4 2019, up 100.82% year-over-year from 46309.82 in Q4 2018, and up 4.49% on a QoQ basis from 89000.0 in Q3 2019.

Healthstream (HSTM) has 3 years of Cash from Discontinued Operations data on file, last reported at 93000.0 in Q4 2019.

  • Quarterly Cash from Discontinued Operations rose 100.82% year-over-year to 93000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was 608000.0 (up 101.84% YoY) and the FY2019 annual result came in at 2053000.0, up 304.48% from the prior year.
  • Cash from Discontinued Operations climbed to 93000.0 in Q4 2019 per HSTM's latest filing, from 89000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 1470000.0 in Q1 2017 and bottomed at 19171000.0 in Q3 2018.
  • The 3-year median for Cash from Discontinued Operations is 13000.0 (2017), against an average of 3138272.73.
  • The widest annual swing landed in 2018, when Cash from Discontinued Operations plunged 11653.85%; it then jumped 142.51% in 2019.
  • Tracing HSTM's Cash from Discontinued Operations over 3 years: stood at 4083000.0 in 2017, then tumbled by 177.32% to 11323000.0 in 2018, then jumped by 100.82% to 93000.0 in 2019.
  • Per Business Quant, the three latest HSTM Cash from Discontinued Operations figures stand at 93000.0 (Q4 2019), 89000.0 (Q3 2019), and 426000.0 (Q1 2019).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn -
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn -
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Healthstream 752.32 Mn 685.82 Mn 68.24 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2019 93,000.00
Dec 31, 2019 93,000.00
Sep 30, 2019 89,000.00
Sep 30, 2019 89,000.00
Mar 31, 2019 426,000.00
Mar 31, 2019 426,000.00
Dec 31, 2018 -11.32 Mn
Dec 31, 2018 -11.32 Mn
Sep 30, 2018 -19.17 Mn
Sep 30, 2018 -19.17 Mn
Jun 30, 2018 -1.50 Mn
Jun 30, 2018 -1.50 Mn
Mar 31, 2018 -1.00 Mn
Mar 31, 2018 -1.00 Mn
Dec 31, 2017 -4.08 Mn
Dec 31, 2017 -4.08 Mn
Sep 30, 2017 469,000.00
Sep 30, 2017 469,000.00
Jun 30, 2017 13,000.00
Jun 30, 2017 13,000.00
Mar 31, 2017 1.47 Mn
Mar 31, 2017 1.47 Mn